Stimulant drug response in the predominantly inattentive and combined subtypes of attention-deficit/hyperactivity disorder. - Wikidata - wikimedia - TriplyDB

Stimulant drug response in the predominantly inattentive and combined subtypes of attention-deficit/hyperactivity disorder.

Stimulant drug response in the predominantly inattentive and combined subtypes of attention-deficit/hyperactivity disorder.

http://www.wikidata.org/entity/Q33694945

about

Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD)From Clinical Application to Cognitive Enhancement: The Example of Methylphenidate Targeting the nicotinic cholinergic system to treat attention-deficit/hyperactivity disorder: rationale and progress to date Predicting acute side effects of stimulant medication in pediatric attention deficit/hyperactivity disorder: data from quantitative electroencephalography, event-related potentials, and a continuous-performance test Long-term neurocognitive effects of methylphenidate in patients with attention deficit hyperactivity disorder, even at drug-free status A two-site randomized clinical trial of integrated psychosocial treatment for ADHD-inattentive type.Protocol investigating the clinical utility of an objective measure of activity and attention (QbTest) on diagnostic and treatment decision-making in children and young people with ADHD-'Assessing QbTest Utility in ADHD' (AQUA): a randomised control ADHD medication reduces cotinine levels and withdrawal in smokers with ADHD Effects of methylphenidate in children with attention deficit hyperactivity disorder: a near-infrared spectroscopy study with CANTAB®Methylphenidate normalizes fronto-striatal underactivation during interference inhibition in medication-naïve boys with attention-deficit hyperactivity disorder Animal models to guide clinical drug development in ADHD: lost in translation?Dose effects and comparative effectiveness of extended release dexmethylphenidate and mixed amphetamine salts The influence of sex-linked genetic mechanisms on attention and impulsivity.Attention deficit hyperactivity disorder subtypes and symptom response in adults treated with lisdexamfetamine dimesylate.Evaluation of the validity of the Psychology Experiment Building Language tests of vigilance, auditory memory, and decision making.Effects of maternal symptom ratings and other clinical features on short-term treatment response to OROS methylphenidate in children and adolescents with ADHD in a naturalistic clinical setting.Adult attention-deficit/hyperactivity disorder: Associations between subtype and lifetime substance use - a clinical study.ADHD and factor analysis: are there really three distinct subtypes of ADHD?Atomoxetine response in the inattentive and combined subtypes of attention deficit hyperactivity disorder: a retrospective chart review.Interventions for attention problems after pediatric traumatic brain injury: what is the evidence?Efficacy of metadoxine extended release in patients with predominantly inattentive subtype attention-deficit/hyperactivity disorder.ADHD symptomatology is best conceptualized as a spectrum: a dimensional versus unitary approach to diagnosis.Genetic Variations in Attention Deficit Hyperactivity Disorder Subtypes and Treatment Resistant Cases Predictors of Response to Behavioral Treatments Among Children With ADHD-Inattentive Type.Changes in Behaviour Symptoms of Patients with Attention Deficit/Hyperactivity Disorder during Treatment: Observation from Different Informants.Meta-Analysis: Reduced Risk of Anxiety with Psychostimulant Treatment in Children with Attention-Deficit/Hyperactivity Disorder.Diagnostic instability of DSM-IV ADHD subtypes: effects of informant source, instrumentation, and methods for combining symptom reports.Dopaminergic and GABA-ergic markers of impulsivity in rats: evidence for anatomical localisation in ventral striatum and prefrontal cortex.Effects of methylphenidate on executive functioning in attention-deficit/hyperactivity disorder across the lifespan: a meta-regression analysis.Evaluation of Two Types of Drug Treatment with QEEG in Children with ADHD

P2860

Q22061981-BEB6BADD-9510-4CAA-B139-A1681DB7EBD0 Q28073785-1A66430F-7850-4E4B-987F-4485618A1C44 Q28250463-2FBED220-5397-4A4F-832B-E50A8F310B91 Q30667435-8D591DA9-25A8-4DD4-B8E1-AECE4EB037FA Q34472512-108C475E-65F2-4A89-8178-649C1DDFFA81 Q34572762-F8F0C605-51A8-4482-935A-B02AD39332EE Q34635231-51E024FC-D797-49D1-AC6D-1FCD406EB618 Q34729003-FDF66E32-21C3-42D7-97BB-641F6C5CFA81 Q34984590-A754FD22-E74F-4739-AE1E-8E159D5F2EC9 Q35050238-0ACD1294-5956-4201-832B-F66003F07813 Q35589937-51708339-1B18-4DD0-A115-B717385AEDF9 Q35625891-C3110307-944C-4200-ACAF-41225EC553DB Q35633377-AD84DD83-F230-41A0-84C4-04DEC618B4B6 Q36100165-8718462B-AAA8-424D-AB14-4F284BA0FD43 Q36725598-038A89C6-0A9F-4C3E-8A0D-95FE64E44854 Q37334076-19C6DF70-6856-4D7E-8820-9F7CDF79EBDE Q37384261-C96F9C11-7589-4B60-B4D2-ECD31C4A3CFC Q38083341-D6B9C19D-6A2E-4D93-B4EC-57DBD524C5EC Q38112064-7CAA6195-DD39-497F-8639-1FC2F8A1CAD1 Q38206345-504F4A61-E199-4944-9F04-23C12C7AAC7F Q38446579-3F0904C7-966E-4AE4-92A9-01C2AE053594 Q38468989-7B214ADD-AC5E-43E4-8537-BD925A0648EC Q38835434-1A15051E-12D4-4841-8FC6-1D5D160D4B87 Q39223712-009DE7CC-0B53-4585-BE60-AB02D8A75F11 Q41513750-91F427DD-908B-46A1-A2F0-DE13E96763A3 Q42170001-105CB5FF-DA97-4BA1-A6F6-9E5220B18519 Q45793574-CFB726CE-3D06-44D3-A91A-197CE570B5C5 Q48183058-8CBFC412-C5CA-466F-A5D7-D0E2F4BB8E74 Q50659644-957AFC28-225D-4E9A-9086-8752A803E641 Q58776317-8FBD1F9A-B66A-4302-9A93-B95950CC644E

P2860

Stimulant drug response in the predominantly inattentive and combined subtypes of attention-deficit/hyperactivity disorder.

http://www.wikidata.org/entity/Q33694945

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

name

Stimulant drug response in the ...... eficit/hyperactivity disorder.

@ast

Stimulant drug response in the ...... eficit/hyperactivity disorder.

@en

type

label

Stimulant drug response in the ...... eficit/hyperactivity disorder.

@ast

Stimulant drug response in the ...... eficit/hyperactivity disorder.

@en

prefLabel

Stimulant drug response in the ...... eficit/hyperactivity disorder.

@ast

Stimulant drug response in the ...... eficit/hyperactivity disorder.

@en

P1433

Q33694945-3F23BA20-8A66-4C03-906E-98909ACEE067

P1476

Q33694945-A9229B3D-992A-4291-9525-03D50F2F93A5

P2093

Q33694945-13983ABB-2D98-4346-9131-B0009AAFEC43

Q33694945-350C1D64-5B71-44F5-8B16-3F60F322FF58

Q33694945-428CBFEE-07AB-4FCC-97AA-BA8CEAFF243C

Q33694945-5FECBC95-ED3B-4BC4-8F7B-2630D2D292A9

Q33694945-8B28475E-529C-4929-AEE4-03DDC1C7130A

Q33694945-ABDB4917-6554-4269-B4A6-1128FADBB6E1

P2860

Q33694945-005C1E7C-E8A0-4968-9E10-701B69269772

Q33694945-0C8F152B-8D7C-4340-A254-0D8016FEF14D

Q33694945-17957CD4-C06A-46C0-956F-D9D825E8812C

Q33694945-1F9A3EA1-FC30-4E82-BEFA-4EE48DB65CE9

Q33694945-2D63A913-1AAA-4BEE-9D7A-7845E1BA5655

Q33694945-38F831BB-0B54-4994-9991-A71F1538E450

Q33694945-3A328B94-CC71-41C5-9C77-FD81322AD8E2

Q33694945-516CDF30-DA66-43BD-9567-EF3A3AA6CBDB

Q33694945-5A7C884A-E87B-4378-9BA3-4C60877A252B

Q33694945-67B405D9-DFD2-4512-BB3C-B5CECF2C7964

P304

Q33694945-37FF5AEB-ADB6-4B64-8C95-B74BC0BB43C4

P31

Q33694945-BA2B8524-1DB0-4559-8A65-DD5D37AC6462

P356

Q33694945-E87B4DEA-375A-4295-B87E-437A781E746F

P433

Q33694945-784962DA-CCED-450A-A8FE-49DC31940288

P478

Q33694945-748DA4D8-8CB2-440C-AA74-29705E03EAEE

P577

Q33694945-F5ED4D02-BE4F-4639-B96C-BFDD85AAE289

P5875

Q33694945-A847F097-2D84-431B-B387-A13FE8575E53

P698

Q33694945-5E971659-1380-4AAC-897E-00789B96A83E

P921

Q33694945-2158C934-AD1F-4B7D-A4AC-89E760B4AB9E

P932

Q33694945-A8268864-D643-40D3-9A97-00BEBAA3F249

P356

P1433

Journal of Child and Adolescent Psychopharmacology

P1476

Stimulant drug response in the ...... eficit/hyperactivity disorder.

@en

P2093

Iliyan Ivanov

http://www.w3.org/2001/XMLSchema#string

Jeffrey Newcorn

http://www.w3.org/2001/XMLSchema#string

Lucia Vail

http://www.w3.org/2001/XMLSchema#string

Mary Solanto

http://www.w3.org/2001/XMLSchema#string

Regina Lara

http://www.w3.org/2001/XMLSchema#string

Sharone Gilbert

http://www.w3.org/2001/XMLSchema#string

P2860

Sluggish cognitive tempo predicts a different pattern of impairment in the attention deficit hyperactivity disorder, predominantly inattentive type

Behavioral inhibition, sustained attention, and executive functions: constructing a unifying theory of ADHD

Neurocognitive Functioning in AD/HD, Predominantly Inattentive and Combined Subtypes

Social functioning and emotional regulation in the attention deficit hyperactivity disorder subtypes.

Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research.

Attention deficit disorder with and without hyperactivity: clinical response to three dose levels of methylphenidate.

Classification of child and adolescent psychopathology.

Attention-deficit/hyperactivity disorder among adolescents: a review of the diagnosis, treatment, and clinical implications.

Social functioning in predominantly inattentive and combined subtypes of children with ADHD.

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle.

P304

663-671

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/CAP.2009.0033

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40784338

http://www.w3.org/2001/XMLSchema#string

P698

20035584

http://www.w3.org/2001/XMLSchema#string

P921

P932

2830210

http://www.w3.org/2001/XMLSchema#string